Purpureocillium lilacinum: A minireview

Table 1 Susceptibility testing method

Antifungal drug	CLSI microdilution (n = 6)	Concentration gradient diffusion assay (n = 5)	EUCAST microdilution (n = 2)	Macrodilution method (n = 2)	Sensititre™ Yeast One™ (n = 2)
Amphotericin B	16.0 (8.0–32.0)	32.0 (32.0–32.0)	36.0 (8.0–64.0)	32.0 (32.0–32.0)	16.0 (16.0–16.0)
Anidulafungin	0.03 (0.03–0.03)	N/A	64.0 (64.0–64.0)	N/A	16.0 (16.0–16.0)
Caspofungin	0.1 (0.03–0.1)	6.0 (2.3–20.0)	4.5 (1.0–8.0)	N/A	40.0 (16.0–64.0)
Micafungin	0.03 (0.03–16.0)	N/A	36.0 (8.0–64.0)	N/A	N/A
Fluconazole	24.0 (12.0–144.0)	N/A	256.0 (256.0–256.0)	128.0 (128.0–128.0)	128.0 (128.0–128.0)
Itraconazole	16.5 (1.0–32.0)	32.0 (8.0–32.0)	24.0 (16.0–32.0)	8.5 (1.0–16.0)	16.5 (1.0–32.0)
Posaconazole	0.1 (0.1–0.1)	0.4 (0.2–0.5)	0.6 (0.3–1.0)	N/A	0.5 (0.5–0.5)
Voriconazole	0.6 (0.3–1.0)	0.1 (0.05–0.2)	0.4 (0.3–0.5)	N/A	0.3 (0.2–0.5)
Ketoconazole	N/A	N/A	N/A	1.0 (1.0–1.0)	N/A
Miconazole	N/A	N/A	N/A	0.5 (0.5–0.5)	N/A
Flucytosine	128.0 (128.0–128.0)	N/A	128.0 (128.0–128.0)	128.0 (128.0–128.0)	32.0 (32.0–32.0)

N/A: Not applicable.